Financial News
Stories about Geron Corp
Geron Rises 4.83% on Heavy Volume: Watch For Potential Pullback (GERN)
November 11, 2010
Shares of Geron are Moving Higher on 1.1x Above-Average Volume (GERN)
November 11, 2010
Geron: The Trend Continues Higher (GERN)
November 11, 2010
Geron Begins Embryonic Stem Cell Treatment In Humans
October 12, 2010
Markets Mixed Over Potential Currency War
October 12, 2010
Tags
Market News
Traders Ride the Bull in Geron as Call Volume Surges (GERN)
October 12, 2010
Geron Call Volume Up 4x as Traders Speculate On Higher Prices (GERN)
October 12, 2010
Getting into stem cells study will be tough-doctor
October 11, 2010
Tags
companyNews
Biotechs may see movement in late trade
October 11, 2010
From MarketWatch
Geron Reports First Patient Enrollment in Stem Cell Trial
October 11, 2010
From FOX Business
FACTBOX-Embryonic stem cells: controversial yet powerful
October 11, 2010
Tags
companyNews
REFILE-UPDATE 1-First US patient treated in stem cell trial
October 11, 2010
Tags
companyNews
SmarTrend's Option Scanner Detects Unusual Activity in Geron (GERN)
September 10, 2010
Rally Loses Steam Despite Jobs Data
September 09, 2010
From FOX Business
Santarus, Geron lead drug stocks north
September 09, 2010
From MarketWatch
Stem-cell stocks regain ground
August 26, 2010
From MarketWatch
Effect on stem cell ruling on companies unclear
August 25, 2010
Tags
companyNews
Biodel, stem-cell biotechs lead drug stock south
August 24, 2010
From MarketWatch
FACTBOX-Embryonic stem cells: controversial yet powerful
August 23, 2010
Tags
companyNews
Geron Trading Higher on 1.2x Above-Average Volume (GERN)
August 04, 2010
Geron Continues Climbing
August 02, 2010
Markets Open Sharply Higher On Upbeat Earnings
August 02, 2010
Tags
Market News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.